Adherence to somatotropin treatment administered with an electronic device

Saz-Parkinson Z, Granados MS, Amate Blanco JM. Adherencia al tratamiento con hormona de crecimiento recombinante en niños deficitarios: control terapéutico e impacto económico. Madrid: Agencia de Evaluación de Tecnologías Sanitarias (AETS), Instituto de Salud Carlos III; 2013. Aydın, 2014, Adherence to growth hormone therapy: results of a multicenter study, Endocr Pract, 20, 46, 10.4158/EP13194.OR Cutfield, 2011, Non-compliance with growth hormone treatment in children is common and impairs lineal growth, PLOS ONE, 6, e16223, 10.1371/journal.pone.0016223 Bozzola, 2011, Treatment adherence with the easypod™ growth hormone electronic autoinjector and patient acceptance: survey results from 824 children and their parents, BMC Endocr Disord, 11, 4, 10.1186/1472-6823-11-4 Carrascosa, 2011, Estudios españoles de crecimiento 2010, Rev Esp Endocrinol Pediatr, 2, 59 Rosenfeld, 2008, Compliance and persistence in pediatric and adult patients receiving growth hormone therapy, Endocr Pract, 14, 143, 10.4158/EP.14.2.143 Smith, 1995, Compliance with growth hormone treatment, are they getting it?, Arch Dis Child, 73, 277, 10.1136/adc.73.3.277-a Oyarzábal, 1998, Multicentre survey on compliance with growth hormone therapy: What can be improved?, Acta Paediatr, 87, 387, 10.1111/j.1651-2227.1998.tb01464.x Fisher, 2013, Understanding the growth hormone therapy adherence paradigm: A systematic review, Horm Res Paediatr, 79, 189, 10.1159/000350251 Bagnasco, 2017, Prevalence and correlates of adherence in children and adolescents treated with growth hormone: a multicenter Italian study, Endocr Pract, 23, 929, 10.4158/EP171786.OR Loche, 2016, Adherence in children with growth hormone deficiency treated with r-hGH and the Easypod™ device, J Endocrinol Invest, 39, 1419, 10.1007/s40618-016-0510-0 Hartmann, 2013, Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders, Horm Res Paediatr, 80, 1, 10.1159/000351800 Haverkamp, 2008, Observations of nonadherence to recombinant human growth hormone therapy in clinical practice, Clin Ther, 30, 307, 10.1016/j.clinthera.2008.02.017 Pfutzner, 2010, Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: a noninterventional, randomized, open-label, crossover, comparative usability study of 3 delivery devices in growth hormone-treated pediatric patients, Clin Ther, 32, 1918, 10.1016/j.clinthera.2010.10.010 Kappelgaard, 2012, Children and adolescent acceptability of a new device system to administer human growth hormone—a pilot study, J Pediatr Endocrinol, 25, 285, 10.1515/jpem-2011-0395 Norgren, 2009, Adherence remains a challenge for patients receiving growth hormone therapy, Pediatr Endocrinol Rev, 6, 545 Raimer-Hall, 2015, Evolution of growth hormone devices: matching devices with patients, Pediatr Nurs, 41, 72 Meinhardt, 2014, Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay, Expert Rev Med Devices, 11, 31, 10.1586/17434440.2014.856754 Gacs, 1991, The effect of socio-economic conditions on the time of diagnosis and compliance during treatment in growth hormone deficiency, Acta Paediatr Hung, 31, 215 Lass, 2015, Low treatment adherence in pubertal children treated with thyroxin or growth hormone, Horm Res Paediatr, 84, 240, 10.1159/000437305 Kapoor, 2008, Monitoring of concordance in growth hormone therapy, Arch Dis Child, 93, 147, 10.1136/adc.2006.114249 López Siguero, 1995, Treatment with growth hormone. What do children know and how do they accept it?, Horm Res, Suppl 3, 18